Novavax, Inc. (NVAX) CEO Stanley Erck on Q3 2021 Results - Earnings Call Transcript

Nov. 04, 2021 10:32 PM ETNovavax, Inc. (NVAX)9 Comments
SA Transcripts profile picture
SA Transcripts
133.62K Followers

Novavax, Inc. (NASDAQ:NVAX) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET

Company Participants

Silvia Taylor - Senior Vice President, Global Corporate Affairs and Investor Relations

Stanley Erck - President and Chief Executive Officer

John Trizzino - Executive Vice President, Chief Commercial Officer and Chief Business Officer

Filip Dubovsky - Executive Vice President, Chief Medical Officer

Jim Kelly - Executive Vice President, Chief Financial Officer and Treasurer

Gregory Glenn - President, Research and Development

Conference Call Participants

Kelechi Chikere - Jefferies

Vernon Bernardino - HC Wainwright

Mayank Mamtani - B. Riley Securities

Charles Duncan - Cantor Fitzgerald

Eric Joseph - JPMorgan

Operator

Ladies and gentlemen, thank you standing by and welcome to the Novavax Third Quarter 2021 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] After the speaker's presentation, there will be an question-and-answer session. [Operator Instructions]. Please be advise that today's conference is being recorded.

I would now like to hand the conference over to your speaker today Silvia Taylor. You may begin.

Silvia Taylor

Thanks very much. Good afternoon, everyone and thank you all for joining us today for our call to discuss our third quarter 2021 operational highlights and financial results. A press release announcing our results is currently available on our website at novavax.com and an audio archive of this conference call will be available on our website later today.

Joining me today is Stan Erck, President and CEO, who will regulatory updates. Additionally John Trizzino, Chief Commercial Officer and Chief Business Officer will discuss our manufacturing and supply updates and the market opportunity for COVID-19 vaccine; and Dr. Filip Dubovsky, Chief Medical Officer will discuss our clinical development. Jim Kelly, Chief Financial Officer and Treasurer will also joined today's call to overview our financial results for the third quarter. Additionally Dr. Greg Glenn, President

Recommended For You

Comments (9)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.